Letermovir as a Rescue Therapy in Kidney Transplant Recipients with Valganciclovir/Ganciclovir Refractory/Resistant Cmv Disease

被引:0
|
作者
von Hoerschelmann, E. [1 ]
Gao, L. [1 ]
Luecht, C. [1 ]
Muench, J. [1 ]
Naik, M. G. [1 ]
Schmidt, D. [1 ]
Weber, U. [1 ]
Choi, M. [1 ]
Halleck, F. [1 ]
Budde, K. [1 ]
机构
[1] Charite, Nephrol, Berlin, Germany
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
D130
引用
收藏
页码:S1118 / S1118
页数:1
相关论文
共 50 条
  • [1] Letermovir Rescue Therapy in Kidney Transplant Recipients with Refractory/Resistant CMV Disease
    von Hoerschelmann, Ellen
    Muench, Johannes
    Gao, Linde
    Luecht, Christian
    Naik, Marcel G.
    Schmidt, Danilo
    Pitzinger, Paul
    Michel, Detlef
    Avaniadi, Parthenopi
    Schrezenmeier, Eva
    Choi, Mira
    Halleck, Fabian
    Budde, Klemens
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [2] Letermovir for CMV Prophylaxis and Treatment of Resistant/Refractory CMV Disease in Solid Organ Transplant Recipients
    Miller, M.
    Scherger, S.
    Benamu, E.
    Bajrovic, V.
    Ramanan, P.
    Madinger, N.
    Barron, M.
    Johnson, S.
    Campbell, T.
    Gray, A.
    Weinberg, A.
    Abidi, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 797 - 797
  • [3] Combining Letermovir with Valganciclovir May Allow an Early Switch From Foscarnet Among Kidney-Transplant-Recipients With Ganciclovir-resistant CMV Infection
    Rho, Elena
    Naef, Bettina
    Wuthrich, Rudolf
    Mueller, Thomas
    Schachtner, Thomas
    Von Moos, Seraina
    SWISS MEDICAL WEEKLY, 2020, : 19S - 19S
  • [4] Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients
    Rho, Elena
    Naef, Bettina
    Mueller, Thomas F.
    Wuethrich, Rudolf P.
    Schachter, Thomas
    von Moos, Seraina
    CLINICAL TRANSPLANTATION, 2021, 35 (11)
  • [5] The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients
    Jorgenson, Margaret R.
    Descourouez, Jillian L.
    Garg, Neetika
    Parajuli, Sandesh
    Mandelbrot, Didier A.
    Odorico, Jon S.
    Saddler, Christopher M.
    Smith, Jeannina A.
    TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [6] The Use of Letermovir for Ganciclovir-Resistant Cytomegalovirus in Kidney Transplant Recipients
    Basic-Jukic, Nikolina
    Atic, Armin
    TURKISH JOURNAL OF NEPHROLOGY, 2022, 31 (03): : 257 - 260
  • [7] Letermovir for treatment of resistant and refractory CMV infections in lung transplant recipients: emergence of resistance
    Veit, T.
    Munker, D.
    Weiglein, T.
    Barton, J.
    Arnold, P.
    Kauke, T.
    Meiser, B.
    Michel, S.
    Zoller, M.
    Nitschko, H.
    Keppler, O.
    Behr, J.
    Kneidinger, N.
    PNEUMOLOGIE, 2024, 78 : S37 - S38
  • [8] Ganciclovir vs. valganciclovir for CMV prophylaxis in solitary pancreas transplant recipients.
    Rea, DJ
    Kudva, YC
    Larson, TS
    Stegall, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 380 - 380
  • [9] Combination Treatment With Letermovir and Ganciclovir for Maintenance Therapy of Multidrug-resistant CMV Infection in a Liver Transplant Recipient
    Kronig, Ilona
    Elkrief, Laure
    Berney, Thierry
    Van Delden, Christian
    Neofytos, Dionysios
    TRANSPLANTATION, 2020, 104 (08) : E248 - E249
  • [10] Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients
    Di Cristanziano, Veronica
    Affeldt, Patrick
    Trappe, Moritz
    Wirtz, Maike
    Heger, Eva
    Knops, Elena
    Kaiser, Rolf
    Stippel, Dirk
    Mueller, Roman-Ulrich
    Holtick, Udo
    Scheid, Christoph
    Kann, Martin
    Kurschat, Christine E.
    Grundmann, Franziska
    MICROORGANISMS, 2021, 9 (08)